The prevention and treatment of obesity. Application to type 2 diabetes.
about
Dietary advice for the prevention of type 2 diabetes mellitus in adultsDietary advice for the prevention of type 2 diabetes mellitus in adultsDietary advice for treatment of type 2 diabetes mellitus in adultsLong-term non-pharmacological weight loss interventions for adults with prediabetesPharmacotherapy for weight loss in adults with type 2 diabetes mellitusLong-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitusPharmacotherapy for weight loss in adults with type 2 diabetes mellitusNutritional modulation of insulin resistanceCardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetesModifications of coronary risk factors.Nurse-led motivational interviewing to change the lifestyle of patients with type 2 diabetes (MILD-project): protocol for a cluster, randomized, controlled trial on implementing lifestyle recommendations.Minimal improvement of nurses' motivational interviewing skills in routine diabetes care one year after training: a cluster randomized trial.The Prevention Of WEight Regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trialMetabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trialsLiving Well with Diabetes: a randomized controlled trial of a telephone-delivered intervention for maintenance of weight loss, physical activity and glycaemic control in adults with type 2 diabetes.Diabetes buddies: peer support through a mobile phone buddy system.Comparisons of weight changes between sodium-glucose cotransporter 2 inhibitors treatment and glucagon-like peptide-1 analogs treatment in type 2 diabetes patients: A meta-analysis.Antiobesity pharmacotherapy in the management of type 2 diabetes.Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database.A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes.Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes?Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes.Dietary treatment and long-term weight loss and maintenance in type 2 diabetes.Orlistat: in the prevention and treatment of type 2 diabetes mellitus.Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment.Body composition and Basal metabolic rate in women with type 2 diabetes mellitus.Orlistat use in type 2 diabetes.Type 2 diabetes outcomes.Biomarkers and functional foods for obesity and diabetes.Working within boundaries: a patient-centered approach to lifestyle change.Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?APOA2 -256T>C polymorphism interacts with saturated fatty acids intake to affect anthropometric and hormonal variables in type 2 diabetic patientsA novel multidisciplinary intervention for long-term weight loss and glycaemic control in obese patients with diabetesPromoting lifestyle change in the prevention and management of type 2 diabetes.Metabolic syndrome frequency in inflammatory bowel diseases.2002 diabetes nutrition recommendations: grading the evidence.Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trialGlutathione peroxidase activity in obese and nonobese diabetic patients and role of hyperglycemia in oxidative stress.Intentional Weight Loss and Longevity in Overweight Patients with Type 2 Diabetes: A Population-Based Cohort Study.Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
P2860
Q24186597-42F00B7B-CF80-417C-8058-53ABBF782608Q24241999-C04AD26C-AF81-4F6B-9064-EE47B5D574BAQ24243869-B21B2CF4-EFC6-47C9-94BA-E3693C7ECB20Q24244294-BFDBD949-5D20-41F6-80A2-D098334533BFQ24245173-4F025A64-5779-4490-B740-7BA46251B185Q24246952-4213E7F4-F42B-48B1-8DB7-B19A07B65BF5Q24250479-8487E7AB-0AE4-4774-9F50-19928F7EBF9DQ26824738-397F166D-0591-43C2-BD4E-6C7D838B5FA8Q28741419-3FB8A16B-2737-4DB1-9872-DB2528F5D90DQ30439801-825ABB2B-8E72-4F83-87D6-B1B212321D82Q30486136-7237ABD6-E1AF-48BE-89BE-AD2C145A132EQ30539227-1139E279-1290-4B68-97A7-EBF23658DDDEQ30578346-ACE5E0D7-A30C-452C-B78B-36908ACC2AE8Q32126634-6892383F-2B95-41FD-AF4B-7050948E9ABCQ33647443-9739E331-DBC5-4AA3-9A6F-853ABBDB38DBQ33762188-D8C6D2AA-A516-4248-A30D-565E7AE6E918Q33871397-538EC0F0-7795-44B3-895D-F869BECA04BBQ33883725-168793FE-3753-434A-94FE-6C9C04A5502AQ34016012-E17EB446-8CF7-4DAA-831D-43F1F5484695Q34022647-05CE2165-2AA5-42A6-9382-4701B6654FC9Q34024099-84507F0B-6972-4257-9275-8D2BCF30DFAFQ34163365-37E2C08D-5FC4-49AA-B3E2-F45BCF60FA0CQ34438263-B58BC735-16D7-4B0F-A205-72E783691396Q34458506-FBDCFB8A-A34D-4641-9500-EB906F528F08Q34507074-0C991525-19CE-4156-A084-A7E05D2FE6C3Q34567873-8DB68D66-58AD-4411-A001-FA318284205CQ34709845-02DDF177-584B-4F09-AC5F-4D4CD6E2AD91Q35006753-049FCFDF-CA78-40FB-AF3B-AC11A92689FEQ35031796-A5C2FC77-7F20-4E13-95CC-0AE3719BD89EQ35084012-49C37BE6-8AD2-42EF-B11E-8B0D4381DCCBQ35087568-0023E39B-1C41-4D36-A6FD-E9883C9D8076Q35529120-A5D4FC68-9361-45DA-AC50-98AC7F46F276Q35534520-A8FFA573-1FC7-447B-81EF-26FCD9E80C51Q35543383-1B03A406-610B-45F7-8FAB-A258C3955D01Q35564312-7F93ED13-DAE2-485F-8AC9-EA78BD689508Q35588161-19A2BDB5-903D-48C0-9504-91585061333BQ35702929-A93DDA6C-810F-4C8C-B040-83E89272F4CBQ35811241-C7410B68-40C1-48C8-A2A1-6CF607C4CB79Q35903685-8B6B9569-85FB-4EA3-9310-A707C817832AQ36012896-3D097D7F-F7BD-49A8-8CC9-FF89CD532FFA
P2860
The prevention and treatment of obesity. Application to type 2 diabetes.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The prevention and treatment of obesity. Application to type 2 diabetes.
@en
type
label
The prevention and treatment of obesity. Application to type 2 diabetes.
@en
prefLabel
The prevention and treatment of obesity. Application to type 2 diabetes.
@en
P1433
P1476
The prevention and treatment of obesity. Application to type 2 diabetes.
@en
P2093
Pi-Sunyer FX
P304
P356
10.2337/DIACARE.20.11.1744
P407
P577
1997-11-01T00:00:00Z